Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001.
Kandzari
David E
DE
Duke Clinical Research Institute, Durham, NC 27715, USA.
Kay
Joseph
J
O'Shea
J Conor
JC
Trichon
Benjamin H
BH
Donahue
Mark
M
Liao
Lawrence
L
Rao
Sunil V
SV
D000572:American Heart Association; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002340:Carotid Artery Diseases / Q000628:therapy*; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control*; D023903:Coronary Restenosis; D016503:Drug Delivery Systems; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D062367:ortho-Aminobenzoates; C012293:tranilast; D017239:Paclitaxel